Alkermes (ALKS) Current Taxes (2015 - 2016)
Alkermes (ALKS) reported Current Taxes of $899000.0 for Q4 2016, down 24.77% year-over-year from $1.2 million in Q1 2016, and up 17.36% quarter-over-quarter from $766000.0 in Q3 2016.
Alkermes (ALKS) Current Taxes (2015 - 2016) Analysis & Trends
Alkermes (ALKS) has 2 years of Current Taxes data on file, last reported at $899000.0 in Q4 2016.
- Current Taxes for Q4 2016 came in at $899000.0, down 24.77% year-over-year; the trailing twelve-month figure through Dec 2016 was $899000.0 (down 24.77% YoY), and the FY2016 annual result was $899000.0, down 24.77% from the prior year.
- Current Taxes advanced to $899000.0 in Q4 2016 per ALKS's latest filing, from $766000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $20.6 million in Q1 2016 and troughed at $766000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 211.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 4.61 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.15 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 3.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 899,000.00 |
| Sep 30, 2016 | 766,000.00 |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 20.63 Mn |
| Dec 31, 2015 | 1.20 Mn |